门诊静脉内输多布他作为右心室支在严重PH-ILD的吸入前环素升级期间
A Kumar1, Siddharth V Ramanan1, Brett Carollo2
1Department of Internal Medicine University of Connecticut School of Medicine Farmington Connecticut USA.
肺高血压与间歇性肺病 (PH-ILD) 的预后不佳. 门诊IV dobutamine可以改善收缩性,并降低吸入treprostinil升级期间的肺血管抵抗.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺高血压与间歇性肺病 (PH-ILD) 与预后不佳有关,特别是当肺血管阻力 (PVR) 超过5木单位 (WU) 时.
- INCREASE试验强调了吸入式特雷普罗斯尼尔对PH-ILD的疗效,但缓慢的剂量升级过程可能会延迟治疗效益.
更多相关视频
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
08:51Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model
Published on: November 11, 2022
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Heart Failure VI: Adjunct Therapies
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
